0001562180-19-002720.txt : 20190508
0001562180-19-002720.hdr.sgml : 20190508
20190508183317
ACCESSION NUMBER: 0001562180-19-002720
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190507
FILED AS OF DATE: 20190508
DATE AS OF CHANGE: 20190508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARSCADDEN GWEN R.
CENTRAL INDEX KEY: 0001590948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 19808179
MAIL ADDRESS:
STREET 1: C/O INTERSECT ENT, INC.
STREET 2: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-05-07
false
0001271214
Intersect ENT, Inc.
XENT
0001590948
CARSCADDEN GWEN R.
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
Chief People Officer
Common Stock
2019-05-07
4
A
false
11952.00
0.00
A
24131.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest on December 31, 2019.
Includes 21,485 Restricted Stock Units.
David A. Lehman, Attorney-in-Fact for Gwen Carscadden
2019-05-08
EX-24
2
poacarscadden.txt
POA CARSCADDEN
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes
and appoints each of LISA D. EARNHARDT,
JERYL L. HILLEMAN, DAVID A. LEHMAN and MATTHEW B. HEMINGTON,
signing individually,
the undersigneds true and lawful
attorneys-in fact and agents to
(1) execute for and on behalf of the undersigned, in the undersigneds
capacity as an officer, director or beneficial
owner of more than 10% of a registered class of
securities of Intersect ENT Inc. (the Company)
(a) Forms 3, 4 and 5 (including any amendments thereto) in accordance with
Section 16(a) of the
Securities Exchange Act of 1934, as amended (the Exchange Act)
and the rules thereunder and a
b) Form ID, Uniform Application for Access Codes to File on EDGAR
(2) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or
desirable to execute such Forms 3, 4 or 5 or Form ID (including any
amendments thereto
and timely file such forms with the United States Securities and
Exchange Commission
and any stock exchange or similar authority and
(3) take any other action of any nature whatsoever in connection with
the foregoing
which, in the opinion of such attorney-in-fact,
may be of benefit, in the best interest of, or legally required
by, the undersigned,
it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this
Power of Attorney
Attorney shall be in such form and shall contain such terms and
conditions as
such attorney-in-fact
may approve in such attorney-in-facts discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority
to do and
perform any and every act and thing whatsoever requisite, necessary
or proper
to be done in the
exercise of any of the rights and powers herein granted, as fully
to all intents
and purposes as the
undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming
all that such
attorney-in-fact, or
such attorney-in-facts substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of
attorney and the
rights and powers
herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact,
in serving in such
capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigneds responsibilities
to comply with
Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until
the earliest to occur
of (a) the
undersigned is no longer required to file Forms 3, 4 and 5 with respect
to the undersigneds
holdings of
and transactions in securities issued by the Company,
(b) revocation by the undersigned in a signed writing delivered
to the foregoing
attorneys-in-fact or (c)
as to any attorney-in-fact individually, until such attorney-in-fact
is no longer
employed by the Company
or Cooley LLP.
IN WITNESS WHEREOF the undersigned has caused this Power of
Attorney to be
executed as of June 27, 2016.
/s/ Gwen Carscadden
Gwen Carscadden